Inhibrx Biosciences, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037
Mailing Address
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037
Phone
(858) 795-4220
Fiscal Year End
1231
EIN
990613523
Financial Overview
FY2025
$180.77M
Total Assets
$152.60M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 19, 2026 | View on SEC |
| 10-K Annual financial report | March 19, 2026 | View on SEC |
| 8-K Current report of material events | February 23, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 11, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 21, 2026 | View on SEC |
| 8-K Current report of material events | December 16, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 8-K Current report of material events | November 14, 2025 | View on SEC |
| 8-K Current report of material events | October 23, 2025 | View on SEC |
Annual Reports
10-K
March 19, 2026
- Inhibrx Biosciences (INBX) is focused on discovering and developing new biologic medicines through early research and human trials.
- The company demonstrates transparency by proactively adopting new accounting rules faster than required for an Emerging Growth Company (EGC).
Related Companies
Companies in the same industry (SIC: 2836)
Passage BIO, Inc.
PASG
Biological Products, (No Diagnostic Substances)
Ginkgo Bioworks Holdings, Inc.
DNA
Biological Products, (No Diagnostic Substances)
CG Oncology, Inc.
CGON
Biological Products, (No Diagnostic Substances)
Odyssey Therapeutics, Inc.
Biological Products, (No Diagnostic Substances)
Aura Biosciences, Inc.
AURA
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.